Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

VBIV Insider Trading

VBIV | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at VBIV provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2023-07-18 16:00 2023-07-10 GILLIS STEVEN Director BUY $1.65 609,090 $1,004,999 1,043,292 +140.3%
2023-04-07 00:51 2023-04-04 PERCEPTIVE ADVISORS LLC 10% owner SELL $0.14 10,894,749 $1,475,149 41,440,729 -20.8%
2021-12-06 18:06 2021-12-03 Beattie Nell Officer - Chief Business Officer BUY $2.45 8,200 $20,083 68,200 +13.7%
2021-12-04 02:22 2021-12-01 PERCEPTIVE ADVISORS LLC 10% owner SELL $3.31 2,707,463 $8,961,703 52,334,993 -4.9%
2021-06-30 23:40 2021-06-29 PERCEPTIVE ADVISORS LLC 10% owner SELL $3.80 646,257 $2,455,777 0 -100.0%
2021-06-12 01:41 2021-06-09 PERCEPTIVE ADVISORS LLC 10% owner SELL $4.00 1,422,567 $5,690,268 145,548 -90.7%
2020-04-28 16:00 2020-04-24 PERCEPTIVE ADVISORS LLC 10% owner BUY $1.10 9,090,909 $10,000,000 55,042,456 +19.8%
2019-10-07 18:35 2019-09-30 Diaz-Mitoma Francisco Officer - Chief Medical Officer BUY $0.50 54,500 $27,250 117,500 +86.5%
2019-10-01 19:39 2019-10-01 Beattie Nell Officer - Chief Business Officer BUY $0.48 10,000 $4,822 60,000 +20.0%
2019-10-01 19:39 2019-10-01 McNulty Christopher Director, Officer - CFO and Head of BD BUY $0.47 12,000 $5,676 37,000 +48.0%
2019-09-30 23:22 2019-09-30 Baxter Jeff Director, Officer - CEO, President BUY $0.50 150,000 $75,450 608,255 +32.7%
2019-09-25 01:30 2019-09-23 PERCEPTIVE ADVISORS LLC 10% owner BUY $0.50 20,000,000 $10,000,000 45,951,556 +77.1%
2019-09-24 03:48 2019-09-19 GILLIS STEVEN Director BUY $0.50 10,000,000 $5,000,000 13,026,057 +330.5%
2019-07-01 13:10 2019-06-27 Diaz-Mitoma Francisco Officer - Chief Medical Officer BUY $1.07 8,000 $8,560 77,500 +11.5%
2019-06-20 22:59 2019-06-20 Diaz-Mitoma Francisco Officer - Chief Medical Officer BUY $0.87 52,000 $45,178 69,500 +297.1%
2019-06-20 17:19 2019-06-18 PERCEPTIVE ADVISORS LLC 10% owner BUY $0.65 1,000,000 $650,000 25,951,556 +4.0%
2019-06-19 19:20 2019-06-19 Beattie Nell Officer - Chief Business Officer BUY $0.74 8,000 $5,886 50,000 +19.0%
2019-06-19 19:17 2019-06-19 Baxter Jeff Director, Officer - CEO, President BUY $0.73 144,000 $105,336 458,255 +45.8%
2019-06-18 18:10 2019-06-17 PERCEPTIVE ADVISORS LLC 10% owner BUY $0.62 1,000,000 $618,000 24,951,556 +4.2%
2018-12-18 20:10 2018-12-17 Kariv Tomer Director BUY $1.40 1,428,571 $1,999,999 185,714 +100.0%
2018-12-17 17:02 2018-12-13 PERCEPTIVE ADVISORS LLC 10% owner BUY $1.40 14,285,714 $20,000,000 23,631,439 +152.9%
2018-08-08 03:38 2018-08-06 Baxter Jeff Director, Officer - CEO, President BUY $1.93 8,100 $15,607 233,005 +3.6%
2018-08-06 21:37 2018-08-02 Diaz-Mitoma Francisco Officer - Chief Medical Officer BUY $2.13 9,000 $19,200 17,500 +105.9%
2018-08-06 18:06 2018-08-03 Baxter Jeff Director, Officer - CEO, President BUY $2.01 13,500 $27,111 224,905 +6.4%
2018-08-03 22:21 2018-08-03 Beattie Nell Officer - Chief Business Officer BUY $2.01 2,000 $4,011 20,750 +10.7%
2018-08-01 20:39 2018-07-31 Baxter Jeff Director, Officer - CEO, President BUY $2.28 16,800 $38,237 211,405 +8.6%
2018-05-25 20:54 2018-05-24 Baxter Jeff Director, Officer - CEO, President BUY $2.99 11,000 $32,890 163,355 +7.2%
2018-05-14 23:56 2018-05-11 Diaz-Mitoma Francisco Officer - Chief Medical Officer BUY $3.05 10,000 $30,475 268,839 +3.9%
2018-05-14 23:54 2018-05-11 Baxter Jeff Director, Officer - CEO, President BUY $2.91 7,100 $20,661 152,355 +4.9%
2017-12-14 01:21 2017-12-12 Baxter Jeff Director, Officer - CEO, President BUY $3.89 10,000 $38,854 145,255 +7.4%
2017-11-29 22:31 2017-11-28 Baxter Jeff Director, Officer - CEO, President BUY $4.75 15,000 $71,250 135,255 +12.5%
2017-11-01 23:11 2017-10-30 Opko Health, Inc. 10% owner BUY $3.05 655,738 $2,000,001 6,678,752 +10.9%
2017-11-01 03:05 2017-10-30 CHAWLA SAM Director BUY $3.05 3,100,000 $9,455,000 9,345,725 +49.6%
2017-11-01 03:07 2017-10-30 GILLIS STEVEN Director BUY $3.05 300,000 $915,000 3,026,057 +11.0%
2017-10-30 23:11 2017-10-26 PERCEPTIVE ADVISORS LLC 10% owner BUY $3.05 3,100,000 $9,455,000 9,345,725 +49.6%
2017-08-22 23:28 2017-08-21 Diaz-Mitoma Francisco Officer - Chief Medical Officer BUY $3.17 3,000 $9,510 3,000 +100.0%
2017-08-22 23:20 2017-08-21 Baxter Jeff Director, Officer - CEO, President BUY $3.22 10,000 $32,200 120,255 +9.1%
2017-08-14 23:42 2017-08-10 Baxter Jeff Director, Officer - CEO, President BUY $3.28 10,000 $32,800 110,255 +10.0%
2017-03-09 21:36 2016-12-06 PERCEPTIVE ADVISORS LLC 10% owner BUY $3.05 3,383,955 $10,321,063 6,245,725 +118.2%
2016-12-08 22:23 2016-12-06 PERCEPTIVE ADVISORS LLC 10% owner BUY $3.05 3,383,955 $10,321,063 6,213,314 +119.6%
2015-08-18 13:45 2015-08-14 PERCEPTIVE ADVISORS LLC 10% owner BUY $2.08 650,000 $1,352,000 3,260,356 +24.9%
SHOW ENTRIES

How to Interpret $VBIV Trades

Not every insider transaction in VBIV is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $VBIV shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for VBIV

Insider activity data for VBIV is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $VBIV, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.